Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Google
Web www.equitybulls.com
Stock Report

| More

Lupin Pharmaceuticals, Inc. Issues Voluntarily Nationwide Recall of Metformin Hydrochloride Extended-Release Tablets, 500mg and 1000mg due to the detection of NDMA impurity

Posted On: 2020-07-07 22:01:40


Lupin Pharmaceuticals Inc. is voluntarily recalling all batches of Metformin Hydrochloride Extended-Release Tablets USP, 500mg and 1000mg to the consumer level. As part of the ongoing assessment and continuation of the dialog with the FDA, additional analysis revealed that certain tested batches were above the Acceptable Daily Intake Limit for the impurity NNitrosodimethylamine (NDMA). Out of an abundance of caution, the company is recalling all batches of Metformin Hydrochloride Extended-Release Tablets USP, 500mg and 1000mg in the US. To date, Lupin Pharmaceuticals Inc. has not received any reports of adverse events related to this recall.

Risk Statement: NDMA is classified as a probable human carcinogen (a substance that could cause cancer) based on results from laboratory tests. NDMA is a known environmental contaminant and found in water and foods, including meats, dairy products and vegetables.

Metformin Hydrochloride Extended-Release Tablets USP is a prescription oral medication indicated as an adjunct to diet and exercise to improve blood glucose control in adults with type 2 diabetes mellitus. Metformin Hydrochloride Extended-Release Tablets USP, 500mg and 1000mg is packaged in 60, 90 and 100 count bottles and was distributed nationwide in the US to wholesalers, distributors, drug chain, mail order pharmacies and supermarkets.

Lupin Pharmaceuticals Inc. is notifying its wholesalers, distributors, drug chain, mail order pharmacies and supermarkets by phone and through recall notification and is arranging for the return of all the recalled product NDC's.

Patients taking Metformin Hydrochloride Extended-Release Tablets, USP 500 mg and 1000mg, are advised to continue taking their medication and contact their pharmacist, physician, or medical provider for advice regarding an alternative treatment. According to the U.S. Food & Drug Administration, it could be dangerous for patients with this serious condition to stop taking their metformin without first talking to their health care professionals. Please visit the agency's website for more information at https://www.fda.gov/drugs/drug-safety-and-availability/fda-updates-and-pressannouncements-ndma-metformin.

Wholesalers, distributors, and retailers that have Metformin Hydrochloride Extended-Release Tablets USP, 500mg and 1000mg that are being recalled should discontinue distribution of the recalled product NDC's immediately and return it to Inmar Rx Solutions, Inc., 635 Vine St, Winston Salem, NC 27101. Tel: (855) 532-1856.

Consumers, wholesalers, distributors, and retailers with questions regarding this recall should contact Inmar Rx Solutions, Inc. at (855) 532-1856 Monday - Friday 09:00 am to 05:00 pm EST. For reimbursement, please have the recalled NDC's returned to Inmar Rx Solutions, Inc.; the NDC number can be found on the top of the bottle label.

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

Shares of LUPIN LTD. was last trading in BSE at Rs.870.8 as compared to the previous close of Rs. 875.65. The total number of shares traded during the day was 98748 in over 3828 trades.

The stock hit an intraday high of Rs. 884.25 and intraday low of 867.65. The net turnover during the day was Rs. 86475360.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com





Other Headlines:

Wonderla Holidays Ltd announces financial results for Q1FY21

Affle reports strong performance for Q1 FY2021

Magma Fincorp Q1FY21 AUM at Rs 15,922 Cr, PAT at Rs 38 Cr vs Rs 11 Cr YoY

Amber Enterprises India Ltd Q1FY21 loss at Rs. 22.44 crore

Neogen Chemicals Ltd Q1 net profit at Rs. 6.11 crore

Majesco shareholders to receive $16.00 in cash per share, agreement with Thoma Bravo amended

Shilpa Medicare Ltd Q1FY21 consolidated PAT zooms to Rs. 86.31 crore

Magma Fincorp Ltd reports Rs. 37.71 crore consolidated PAT in Q1

VBC Ferro Alloys Ltd posts Q1 loss of Rs. 0.78 crore

Wonderla Holidays Ltd Q1 loss at Rs. 14.51 crore

Rama Phosphates Ltd Q1 PAT up at Rs. 6.56 crore

Shaily Engineering Plastics Ltd posts Rs. 3.02 crore loss in Q1

Shilp Gravures Ltd Q1 net profit at Rs. 0.73 crore

Affle India Ltd posts consolidated net profit of Rs. 18.77 crore in Q1

SPL Industries Ltd Q1 net profit at Rs. 2.64 crore

Fire at Nandan Denim's factory

Avanti Feeds Ltd board to consider Q1 results on Aug 27, 2020

Minda Industries Ltd issues commercial paper of Rs. 25 crore

Info Edge India Ltd closes QIP, fixes issue price as Rs. 3090

Kriti Nutrients Ltd Q1FY21 net profit rises to Rs. 8.16 crore

TVS Electronics Ltd Q1 loss at Rs. 9.75 crore

ZEN Technologies Ltd Q1 loss at Rs. 1.33 crore

DCB Bank Ltd reports Rs. 79.38 crore PAT in Q1FY21

Arihant Capital Markets Ltd Q1FY21 consolidated PAT at Rs. 4.88 crore

RAMCO Systems Ltd posts consolidated PAT of Rs. 13.81 crore in Q1FY21

Bajaj Hindusthan Sugar Ltd Q1 consolidated loss at Rs. 52.89 crore

ARO Granite Industries Ltd Q1 net profit at Rs. 0.34 crore

Nitin Spinners Ltd Q1 loss at Rs. 9.15 crore

Sarda Energy & Minerals Ltd Q1 FY21 consolidated PAT jumps QoQ to Rs. 35.47 crore

Kriti Industries India Ltd Q1 consolidated net profit at Rs. 6.84 crore

Ambika Cotton Mills Ltd posts drop in Q1 PAT to Rs. 5.01 crore

Divi's Laboratories Ltd Q1FY21 consolidated net profit climbs to Rs. 492.06 crore

Geojit Financial Services - Company Update - August 2020 - ICICI Securities

ELGi's AB 'Always Better' Series powers the Indian pharmaceutical industry

Dish TV India to telecast live 'With Sadhguru in Challenging Times' on DishTV and D2H platforms

Newgen's Virtual Meet on Preparing for a Digital-Only World Receives Overwhelming Response

PNB Housing Finance Limited Announces MD & CEO Transition

Canara Bank slashes Interest rates on loans/advances with effect from 07.08.2020

Abbott India Ltd posts Rs. 180.35 crore PAT in Q1FY21

FDC Limited to acquire further stake in South Africa firm

Energy Development Company Ltd board recommends dividend of Rs. 0.50

Hero MotoCorp donates unique first responder vehicles to Civil Hospital, Gurugram

Mirchi revenues fall 72%, but market share rises to 33%

FDC Ltd board approves buy-back at Rs. 450

Gujarat Themis Biosyn Ltd board to approve quarterly results on Aug 13, 2020

Ravileela Granites Ltd Q1 consolidated net profit up at Rs. 0.74 crore

Indowind Energy Ltd posts consolidated PAT of Rs. 3.40 crore in Q1

FDC Ltd reports consolidated PAT of Rs. 91.72 crore in Q1FY21

Mercury Laboratories Ltd Q1 PAT at Rs. 0.96 crore

BATA India Ltd reports loss of Rs. 100.88 crore in Q1FY21







Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2019